Compare Globus Medical Inc. Class A Common Stock (GMED) vs MGM Resorts International (MGM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs MGM Resorts International — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while MGM Resorts International trades at $29.12 (market cap $7.29B). The key difference: Globus Medical Inc. Class A Common Stock is the larger of the two by market cap, and MGM Resorts International pays a 0.03% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and MGM Resorts International for 92 Days on average.
| GMED | MGM | |
|---|---|---|
Market Cap | $10.25B | $7.29B |
Volume | 1,059,528 | 4,222,588 |
Sector | Health | Consumer Cyclical |
52-Week High | $96.82 | $50.69 |
52-Week Low | $58.33 | $28.96 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $9.76B | $34.59B |
Dividend Yield | — | 0.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
MGM Resorts International (MGM) trades at $29.40, showing modest daily gains of 0.27% but facing significant bearish technical pressure with 19 sell signals versus 5 buy signals. The company maintains stable revenue around $17.5B annually but faces profitability challenges with net margins declining from 11.22% in 2022 to just 1.17% in 2025. Recent market volatility stems from Barry Diller's withdrawn $48.30 per share acquisition offer, causing substantial stock declines despite strong analyst support with 51% buy ratings and a $47.57 consensus target.
MGM presents a compelling valuation case with attractive P/S (0.44) and P/E (17.82) ratios, though near-term headwinds include weak technical momentum and earnings volatility. The stock's 36% discount to analyst targets offers upside potential, but investors must weigh acquisition uncertainty against fundamental stability in the gaming sector. Key catalysts include Q3 2026 earnings on October 28 and potential strategic moves regarding People Inc.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →
